Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Winston, Alan, Amin, Janaki, Clarke, Amanda, Else, Laura, Amara, Alieu, Owen, Andrew, Barber, Tristan, Jessen, Heiko, Avinghsanon, Anchalee, Chetchotisakd, Ploenchan
et al (show 5 more authors) (2015) Cerebrospinal Fluid Exposure of Efavirenz and Its Major Metabolites When Dosed at 400 mg and 600 mg Once Daily: A Randomized Controlled Trial. CLINICAL INFECTIOUS DISEASES, 60 (7). 1026 - 1032.


Amara, Alieu B, Else, Laura J, Carey, Dianne, Khoo, Saye, Back, David J, Amin, Janaki, Emery, Sean and Puls, Rebekah L
(2017) Comparison of Dried Blood Spots Versus Conventional Plasma Collection for the Characterization of Efavirenz Pharmacokinetics in a Large-Scale Global Clinical Trial-The ENCORE1 Study. THERAPEUTIC DRUG MONITORING, 39 (6). 654 - 658.


Amara, Alieu B, Else, Laura J, Carey, Dianne, Khoo, Saye, Back, David J, Amin, Janaki, Emery, Sean and Puls, Rebekah L
(2017) Comparison of Dried Blood Spots Versus Conventional Plasma Collection for the Characterization of Efavirenz Pharmacokinetics in a Large-Scale Global Clinical Trial-The ENCORE1 Study. Therapeutic drug monitoring, 39 (6). 654 - 658.


Dickinson, Laura, Amin, Janaki ORCID: 0000-0003-2161-9366, Else, Laura, Boffito, Marta, Egan, Deirdre, Owen, Andrew, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Orrell, Catherine, Clarke, Amanda
et al (show 6 more authors) (2016) Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naive HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study. CLINICAL PHARMACOKINETICS, 55 (7). 861 - 873.

This list was generated on Wed Dec 5 05:54:28 2018 GMT.